{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:02:50Z","timestamp":1781020970846,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L232082"],"award-info":[{"award-number":["L232082"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z181100001718182"],"award-info":[{"award-number":["Z181100001718182"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270133"],"award-info":[{"award-number":["82270133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.thromres.2025.109528","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:35:34Z","timestamp":1761982534000},"page":"109528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Chinese Haemophilia Individualized Prophylaxis (CHIPS): A cost-effective regimen for zero joint bleeding and long-term joint health in boys with Severe Haemophilia A (SHA) on factor replacement"],"prefix":"10.1016","volume":"256","author":[{"given":"Wanru","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon-Hung","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109528_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"Wfh guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/hae.14101","article-title":"Haemophilia care in China: achievements in the past decade","volume":"26","author":"Dou","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2516.2010.02348.x","article-title":"Low dose secondary prophylaxis reduces joint bleeding in severe and moderate hemophilia children: a pilot study in China","volume":"17","author":"Wu","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2516.2012.02926.x","article-title":"Short-term low dose secondary prophylaxis for severe\/moderate hemophilia a children is beneficial to reduce bleed and improve daily activity, but there are obstacles in its execution: a multi-Centre pilot study in China","volume":"19","author":"Tang","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0025","first-page":"1128","article-title":"Efficacy and safety of recombinant coagulation factor IX in moderate and severe hemophilia B children in China: a single-centre observation study","volume":"28","author":"Li","year":"2013","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"key":"10.1016\/j.thromres.2025.109528_bb0030","first-page":"632","article-title":"Long-term low dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-centre observation","volume":"3","author":"Wu","year":"2013","journal-title":"Chin. J. Hematol."},{"key":"10.1016\/j.thromres.2025.109528_bb0035","first-page":"164","article-title":"Modified long-term low dose secondary prophylaxis for severe and moderate hemophilia a children with arthropathy: a single-Centre prospective study in China, WFH 2012 world congress, abstract","volume":"18","author":"Wu","year":"2012","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2025.109528_bb0040","first-page":"395","article-title":"Individualized escalation ladder prophylaxis and therapeutic efficacy review in 4 children with severe hemophilia A","volume":"22","author":"Li","year":"2016","journal-title":"Chin. J. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109528_bb0045","first-page":"923","article-title":"Analysis of individualized primary prophylaxis treatment of 19 cases of children with severe hemophilia a","volume":"54","author":"Liu","year":"2016","journal-title":"Chin. J. Pediatr."},{"issue":"7","key":"10.1016\/j.thromres.2025.109528_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1076029616679507","article-title":"The efficacy of recombinant FVIII low dose prophylaxis in Chinese pediatric patients with severe hemophilia a: a retrospective analysis from the ReCARE study","volume":"23","author":"Yao","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109528_bb0055","first-page":"78","article-title":"Intracranial hemorrhage occurred in children with severe hemophilia under different treatment","volume":"22","author":"Fu","year":"2017","journal-title":"J. China Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2025.109528_bb0060","first-page":"398","article-title":"Low dose tertiary prophylactic therapy for severe hemophilia A adults in a single medical Centre in Beijing area","volume":"37","author":"Lian","year":"2015","journal-title":"Acta Acad. Med. Sin."},{"key":"10.1016\/j.thromres.2025.109528_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/hae.13182","article-title":"Low dose factor VIII infusion in Chinese adult hemophilia a patients: pharmacokinetic evidence that daily infusion results in higher trough level than every-other-day infusion with similar factor VIII consumption","volume":"23","author":"Hua","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0070","first-page":"282","article-title":"Evaluation of low-dose prophylactic therapy in 48 pediatric cases of hemophilia a","volume":"21","author":"Zhang","year":"2015","journal-title":"Chin. J. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109528_bb0075","first-page":"257","article-title":"Efficacy observation of low-dose prophylactic therapy in pediatric hemophilia a","volume":"35","author":"Hu","year":"2013","journal-title":"Beijing Med. J."},{"key":"10.1016\/j.thromres.2025.109528_bb0080","first-page":"2406","article-title":"Comparison of low-dose prophylactic efficacy between pediatric and adult patients with severe hemophilia A","volume":"37","author":"Li","year":"2016","journal-title":"Guangdong Med. J."},{"key":"10.1016\/j.thromres.2025.109528_bb0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/hae.12838","article-title":"A randomized study of very low-dose factor VIII prophylaxis in severe haemophilia\u2014a success story from a resource-limited country","volume":"22","author":"Verma","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/hae.12853","article-title":"Low-dose prophylaxis for severe haemophilia: a little goes a long way","volume":"22","author":"Fischer","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/17474086.2017.1386096","article-title":"The benefit of low dose prophylaxis in the treatment of hemophilia: a focus on China","volume":"10","author":"Wu","year":"2017","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.thromres.2025.109528_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-10-112","article-title":"Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China","volume":"10","author":"Wu","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.thromres.2025.109528_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rth2.12552","article-title":"Significant reduction in hemarthrosis in boys with severe hemophilia A: the China hemophilia individualized low-dose secondary prophylaxis study","volume":"5","author":"Wu","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109528_bb0110","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1111\/hae.14635","article-title":"Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia a","volume":"28","author":"Huang","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2024.109110","article-title":"A long term outcomes analysis of severe haemophilia a boys receiving 4 years prophylaxis on the Chinese Haemophilia individualized escalating low dose prophylaxis (CHIPS)","volume":"241","author":"Yao","year":"2024","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109528_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/bjh.18420","article-title":"A phase 1b\/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia","volume":"200","author":"Mahlangu","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109528_bb0125","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa2302982","article-title":"Gene therapy with fidanacogene elaparvovec in adults with hemophilia B","volume":"391","author":"Cuker","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2025.109528_bb0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2516.2006.01312.x","article-title":"Hemophilia joint health score reliability study","volume":"12","author":"Hilliard","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0135","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1365-2516.2009.02016.x","article-title":"Refinement of a sonographic protocol for assessment of haemophilic arthropathy","volume":"15","author":"Keshava","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2516.2006.01414.x","article-title":"Sonography for assessment of haemophilic arthropathy in children: a systematic protocol","volume":"13","author":"Zukotynski","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0145","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1365-2516.2009.02016.x","article-title":"Refinement of a sonographic protocol for assessment of haemophilic arthropathy","volume":"15","author":"Keshava","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13244-021-01043-0","article-title":"A semiquantitative color Doppler ultrasound scoring system for evaluation of synovitis in joints of patients with blood-induced arthropathy","volume":"12","author":"Zhang","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1016\/j.thromres.2025.109528_bb0155","first-page":"236","article-title":"Efficacy of pharmacokinetic-guided prophylactic therapy in children with hemophilia A","volume":"29","author":"Zhang","year":"2024","journal-title":"Chin. J. Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2025.109528_bb0160","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S2352-3026(18)30048-6","article-title":"Tailored frequency-escalated primary prophylaxis for severe haemophilia a: results of the 16-year Canadian hemophilia prophylaxis study longitudinal cohort","volume":"5","author":"Feldman","year":"2018","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2025.109528_bb0165","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood.2020005673","article-title":"Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia a: results from the phase 3 PROPEL study","volume":"137","author":"Klamroth","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109528_bb0170","first-page":"1","article-title":"Standard for the establishment of hemophilia center (Version 2024)","volume":"30","author":"Treatment","year":"2024"},{"key":"10.1016\/j.thromres.2025.109528_bb0175","first-page":"402","article-title":"Analysis of the efficacy and safety of emicizumab in the treatment of hemophilia a in children","volume":"20 Dec","author":"Xu","year":"2024","journal-title":"J. China Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.thromres.2025.109528_bb0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ped4.12439","article-title":"Real-world use of Emicizumab in Chinese children with hemophilia a: retrospective data from a compreh ensive care center","volume":"8","author":"Mao","year":"2024","journal-title":"Pediatr. Investig."},{"key":"10.1016\/j.thromres.2025.109528_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2022.992267","article-title":"Real-world experience of emicizumab prophylaxis in young children with hemophilia a: retrospective data from China","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.thromres.2025.109528_bb0190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/hae.15062","article-title":"Reduced doses of emicizumab achieve good efficacy: results from a national-wide multicentre real-world study in China","volume":"30","author":"Xu","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109528_bb0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0040-1717114","article-title":"Pharmacokinetics and pharmacodynamics of emicizumab in persons with hemophilia a with factor VIII inhibitors: HAVEN 1 study","volume":"121","author":"Schmitt","year":"2021","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:41:11Z","timestamp":1781019671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"alternative-id":["S0049384825002786"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109528","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Chinese Haemophilia Individualized Prophylaxis (CHIPS): A cost-effective regimen for zero joint bleeding and long-term joint health in boys with Severe Haemophilia A (SHA) on factor replacement","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109528"}}